v
irus
recur
threat
human
health
worldwid
highli
preval
diseas
hiv
dengu
influenza
emerg
virus
ebola
sar
middl
east
respiratori
syndrom
coronaviru
viral
infect
caus
seriou
diseas
requir
activ
treatment
prevent
morbid
mortal
effect
antivir
drug
avail
nine
virus
includ
hiv
hepat
b
viru
hepat
c
viru
herpesviru
influenza
viru
human
cytomegaloviru
varicellazost
viru
respiratori
syncyti
viru
extern
anogenit
wart
caus
human
papillomaviru
howev
viral
diseas
lack
effect
drug
treatment
de
clercq
li
lack
narrow
broad
spectrum
antivir
defici
modern
medic
formulari
defici
due
larg
part
genet
replicationcycl
divers
virus
oneviru
onedrug
mindset
model
use
current
antivir
therapi
current
market
antivir
develop
interact
specif
viral
protein
viru
interest
eg
hiv
integras
proteas
shown
signific
util
virus
one
approach
identifi
broadspectrum
antivir
investig
host
protein
cofactor
shown
associ
viral
replic
target
small
molecul
way
block
viral
infect
uncov
host
protein
metabol
pathway
import
multipl
virus
open
door
develop
broad
spectrum
inhibitor
viral
infect
wide
recogn
virus
depend
host
cellular
protein
machineri
multipl
point
replic
cycl
make
host
factor
broadli
use
mani
virus
attract
antivir
target
virus
use
protein
synthesi
machineri
drive
translat
mrna
identifi
compon
translat
machineri
use
multipl
viral
famili
offer
signific
opportun
develop
broad
spectrum
antivir
approach
inhibit
eukaryot
initi
factor
function
recent
emerg
potenti
target
type
intervent
translat
factor
undergo
uniqu
posttransl
modif
call
hypusin
hypusin
occur
lysin
twoenzym
cascad
aminobutyl
moieti
polyamin
spermidin
becom
incorpor
deoxyhypusin
synthas
dhp
hydroxyl
deoxyhypusin
hydroxylas
dohh
form
hypusin
residu
fig
fig
cartoon
represent
hypusin
pathway
hypusin
two
enzym
cascad
aminobutyl
group
polyamin
spermidin
first
coval
attach
lysin
deoxyhypusin
synthas
dhp
hydroxyl
deoxyhypusin
hydroxylas
dohh
small
molecul
inhibitor
enzym
also
depict
cellular
protein
contain
hypusin
hypusin
critic
function
park
et
al
hypusin
suggest
involv
mani
cellular
process
origin
identifi
stimul
dipeptid
synthesi
kemper
et
al
schreier
et
al
benn
hershey
recent
suggest
import
mrna
nucleocytoplasm
transport
ruhl
et
al
bevec
et
al
elfgang
et
al
mrna
stabil
zuk
jacobson
schrader
et
al
translat
hard
translat
region
polyprolin
stretch
gutierrez
et
al
cellular
function
review
detail
elsewher
dever
et
al
rossi
et
al
increas
evid
suggest
play
import
role
modul
viru
replic
hiv
first
viru
suggest
requir
depend
revdepend
nucleocytoplasm
transport
fig
rev
transactiv
protein
mediat
transloc
viral
mrna
nucleu
cytoplasm
essenti
express
viral
structur
protein
malim
et
al
specif
bind
rev
ruhl
et
al
lossoffunct
mutant
block
nuclear
export
rev
protein
replic
bevec
et
al
furthermor
inhibit
hypusin
also
shown
inhibit
hiv
replic
andru
et
al
hauber
et
al
hoqu
et
al
schroeder
et
al
taken
togeth
data
suggest
pathway
may
interest
target
develop
hiv
therapeut
recent
work
group
suggest
also
play
role
replic
filovirus
ebola
viru
ebov
marburg
viru
marv
olsen
et
al
deplet
follow
infect
ebov
marv
result
log
reduct
infecti
titer
virus
mechanist
probe
util
ebov
transcript
replic
minigenom
assay
reveal
defect
report
gene
express
indic
requir
ebov
gene
express
andor
genom
replic
furthermor
accumul
ebov
protein
reduc
presenc
hypusin
inhibitor
requir
ebov
gene
express
reduct
result
reduc
report
gene
express
minigenom
assay
like
halt
viral
gene
express
viral
infect
fig
result
suggest
target
hypusin
may
provid
therapeut
target
develop
antivir
treat
hemorrhag
fever
virus
appreci
multipl
divers
viru
famili
requir
replic
suggest
block
function
might
broad
spectrum
antivir
approach
sever
molecul
develop
target
hypusin
twostep
hypusin
pathway
offer
two
enzym
directli
target
compound
ciclopirox
cpx
deferipron
def
use
clinic
topic
antifung
agent
inhibit
dohh
park
et
al
cell
cultur
experi
cpx
def
reduc
hiv
hoqu
et
al
filoviru
replic
olsen
et
al
make
strong
candid
drug
repurpos
furthermor
cpx
test
vivo
anim
model
variou
human
diseas
recent
test
phase
clinic
trial
patient
hematolog
malign
review
shen
huang
anoth
compound
semapimod
guanylhydrazon
effici
inhibit
hypusin
target
dhp
also
shown
interfer
replic
hauber
et
al
second
approach
inhibit
hypusin
add
nonfunct
substrat
inhibit
hypusin
synthesi
enzym
spermidin
analogu
competit
inhibitor
dh
jaku
et
al
recent
work
show
effect
compound
control
ebov
replic
suggest
compound
may
effect
antivir
olsen
et
al
anoth
spermidin
analogu
diaminooctan
shown
inhibit
hiv
replic
vitro
hart
et
al
find
suggest
inhibit
hypusin
substrat
competit
dhp
possibl
extens
studi
antitumor
agent
review
nakanishi
cleveland
well
vivo
sever
applic
imam
et
al
meli
et
al
anim
model
test
efficaci
logic
next
step
investig
import
viru
replic
pathogenesi
viru
replic
attack
block
pathway
upstream
alter
level
polyamin
spermidin
spermin
putrescin
inhibit
polyamin
synthesi
pathway
use
compound
difluoromethylornithin
current
use
reduc
trypanosom
level
infect
individu
result
decreas
viral
replic
numer
rna
virus
mounc
et
al
mounc
et
al
olsen
et
al
virus
sensit
polyamin
deplet
includ
flavivirus
dengu
zika
bunyavirus
rift
valley
fever
picornavirus
polio
coxsackieviru
mounc
et
al
exact
mechan
viral
sensit
polyamin
level
fulli
understood
requir
spermidin
hypusin
could
offer
explan
import
studi
move
forward
nonspecif
side
effect
alway
concern
associ
cellular
process
target
way
block
viru
replic
certainli
risk
target
host
translat
machineri
gener
antivir
strategi
normal
synthesi
host
protein
integr
part
cellular
organism
homeostasi
target
hypusin
would
like
limit
offtarget
effect
one
would
expect
global
translat
inhibit
import
translat
discreet
subset
protein
fujimura
et
al
current
compound
block
hypusin
avail
develop
antivir
may
caus
addit
offtarget
effect
cpx
target
multipl
enzym
pathway
includ
limit
ribonucleotid
reductas
wntbcatenin
vegf
mtor
cyclindepend
kinas
could
lead
undesir
offtarget
effect
antivir
although
toler
anim
studi
shen
huang
similarli
multival
compound
interfer
sever
pathway
includ
synthesi
tnf
phosphoryl
mapk
furthermor
clinic
applic
use
spermidin
analogu
diaminooctan
also
unclear
given
could
potenti
affect
enzym
respons
spermidin
toward
allevi
issu
novel
compound
target
dhp
use
crystal
structur
dhp
bound
design
base
synthes
test
inhibit
replic
schroeder
et
al
target
hypusin
broad
spectrum
antivir
approach
excit
possibl
earli
stage
develop
challeng
remain
idea
establish
whether
pathway
antivir
target
includ
vivo
test
relev
anim
model
develop
addit
small
molecul
inhibitorscompound
target
hypusin
given
import
viral
replic
cancer
biolog
opportun
multidisciplinari
approach
address
concern
furthermor
combin
therapi
target
host
viral
target
antivir
efficaci
may
improv
reduc
emerg
viral
resist
minim
toxic
control
viral
infect
epidem
viral
diseas
